Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,130 | -1,192 | -4,619 | -3,930 | -2,607 |
| Depreciation Amortization | 1 | 1 | 2 | 1 | N/A |
| Accounts receivable | -3 | -37 | 81 | 61 | 86 |
| Accounts payable and accrued liabilities | 40 | 156 | -246 | -81 | -362 |
| Other Working Capital | -668 | -606 | -9 | 30 | -183 |
| Other Operating Activity | 452 | 290 | 1,641 | 1,497 | 1,333 |
| Operating Cash Flow | $-2,307 | $-1,388 | $-3,150 | $-2,423 | $-1,733 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -14 | -14 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-14 | $-14 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 200 | 200 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 1,337 | -275 | -275 |
| Financing Cash Flow | $200 | $200 | $1,337 | $-275 | $-275 |
| Beginning Cash Position | 3,294 | 3,294 | 5,122 | 5,122 | 5,122 |
| End Cash Position | 1,187 | 2,105 | 3,294 | 2,410 | 3,114 |
| Net Cash Flow | $-2,107 | $-1,188 | $-1,828 | $-2,712 | $-2,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,307 | -1,388 | -3,150 | -2,423 | -1,733 |
| Capital Expenditure | N/A | N/A | -14 | -14 | N/A |
| Free Cash Flow | -2,307 | -1,388 | -3,165 | -2,437 | -1,733 |